48,274 Shares in Cencora, Inc. $COR Purchased by Callan Family Office LLC

Callan Family Office LLC bought a new position in shares of Cencora, Inc. (NYSE:COR) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 48,274 shares of the company’s stock, valued at approximately $13,661,000.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Kemnay Advisory Services Inc. acquired a new position in Cencora during the fourth quarter worth $25,000. Oakworth Capital Inc. purchased a new stake in Cencora during the fourth quarter worth $26,000. Elyxium Wealth LLC acquired a new stake in Cencora in the fourth quarter valued at $27,000. Archer Investment Corp grew its holdings in Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC purchased a new position in shares of Cencora in the fourth quarter valued at $29,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have recently issued reports on COR shares. William Blair initiated coverage on Cencora in a research note on Tuesday, April 28th. They set a “market perform” rating for the company. Morgan Stanley increased their price objective on shares of Cencora from $342.00 to $346.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. Citigroup restated a “buy” rating on shares of Cencora in a report on Thursday, August 6th. Weiss Ratings raised shares of Cencora from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 6th. Finally, Royal Bank Of Canada began coverage on shares of Cencora in a report on Wednesday. They issued a “sector perform” rating and a $330.00 price target on the stock. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Cencora currently has an average rating of “Moderate Buy” and a consensus target price of $370.85.

Cencora Trading Up 1.0%

Shares of COR stock opened at $317.89 on Friday. The firm’s 50-day simple moving average is $302.59 and its 200-day simple moving average is $311.89. The company has a debt-to-equity ratio of 3.53, a current ratio of 0.93 and a quick ratio of 0.58. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54. The firm has a market cap of $60.66 billion, a P/E ratio of 23.62, a PEG ratio of 1.81 and a beta of 0.57.

Cencora (NYSE:COR) last released its earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.35 by $0.13. The firm had revenue of $84.75 billion during the quarter, compared to the consensus estimate of $84.31 billion. Cencora had a net margin of 0.79% and a return on equity of 125.45%. Cencora’s revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.00 earnings per share. As a group, equities analysts forecast that Cencora, Inc. will post 17.87 EPS for the current year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be paid a dividend of $0.60 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. Cencora’s payout ratio is currently 17.83%.

Cencora announced that its Board of Directors has approved a stock buyback program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to repurchase up to 3.9% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Insider Activity at Cencora

In other news, Director Lauren M. Tyler acquired 550 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was acquired at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the acquisition, the director directly owned 4,359 shares in the company, valued at approximately $1,177,932.57. This represents a 14.44% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.38% of the stock is currently owned by insiders.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.